Organization : Basilea

Organization

Basilea's board, management committee and extended management committee members have extensive experience in the pharmaceutical industry.

“Good corporate governance is an essential pre requisite for corporate success and sustainable growth of company value.”

Swiss Code of Best Practice for Corporate Governance

Board of directors

Stephan Schindler

Chairman of the board

Thomas Werner, Ph.D.

Vice-chairman of the board of directors

Leonard Kruimer

Member of the board of directors

Martin Nicklasson, Ph.D.

Member of the board of directors

Nicole Onetto, M.D.

Member of the board of directors

Carole Sable, M.D.

Member of the board of directors

Our mission:

"We aim to be a leading provider of innovative medicines. For the benefit of patients."

Board committees

Audit committee	Compensation committee	Corporate governance & nomination committee
Leonard Kruimer (Chair)	Dr. Nicole Onetto (Chair)	Dr. Thomas Werner (Chair)
Dr. Martin Nicklasson	Leonard Kruimer	Dr. Carole Sable
Stephan Schindler	Dr. Martin Nicklasson	Stephan Schindler

For further information on the responsibilities of the board committees, please refer to the latest annual report.

Management committee

Chief Executive Officer

Marc Engelhardt, M.D.

Chief Medical Officer

Gerrit Hauck, Ph.D.

Chief Technology Officer

Chief Financial Officer

Laurenz Kellenberger, Ph.D.

Chief Scientific Officer

Extended management committee

Peter Bielmeier, Ph.D.

Head of Global Quality Management

Ursula Eberhardt

Head of Global Human Resources

Raimond Grewenig-Scheurich

Head of Global Commercial

General Counsel & Corporate Secretary

Mark Jones, Ph.D.

Head of Global Affairs